New CRISPR tool executes multiple edits simultaneously, leading to unique partnership to deliver more precise cancer treatments
(Burness) Scientists at Christiana Care Health System's Gene Editing Institute and NovellusDx, an Israeli biotechnology company, have deployed a breakthrough CRISPR gene-editing tool to successfully engineer multiple edits simultaneously to fragments of DNA extracted from a human cell, according to a new study published today in The CRISPR Journal. The tool can rapidly reproduce, in a human DNA sample, the unique and complex genetic features of an individual patient's cancer tumor.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Genetics | Israel Health | Partnerships | Study